Search company, investor...


Founded Year



Acquired | Acquired

Total Raised




About Valeritas

Valeritas is committed to developing and commercializing treatment solutions that contribute to clinical and humanistic outcomes for patients, with an initial focus on the treatment of Type 2 diabetes. Valeritas' portfolio is headlined by the V-Go disposable insulin delivery device, which is being commercialized and reimbursed in a specialty pharmaceutical model and is distributed through retail pharmacy. In addition to the V-Go, Valeritas' delivery technology portfolio includes the h-Patch for the delivery of other compounds beyond insulin, the Mini-Ject Pre-Filled Needle-Free Delivery System, and the Micro-Trans Microneedle Transdermal Delivery Patch. These technologies, when combined with certain compounds, are designed to provide products that allow precise dosing in previously difficult to treat conditions.On February 10th, 2020, Valeritas was acquired by Zealand million.

Headquarters Location

750 Route 202 South Suite 100

Bridgewater, New Jersey, 08807,

United States


Missing: Valeritas's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Valeritas's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Valeritas

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Valeritas is included in 4 Expert Collections, including Medical Devices.


Medical Devices

8,537 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.



1,895 items


Health IT

7,901 items

Valeritas Patents

Valeritas has filed 1 patent.

The 3 most popular patent topics include:

  • Fluid dynamics
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date


Related Topics




Medical equipment, Drug delivery devices, Fluid dynamics, Pumps, Plunger-class submarines


Application Date


Grant Date



Related Topics

Medical equipment, Drug delivery devices, Fluid dynamics, Pumps, Plunger-class submarines



Latest Valeritas News

Worldwide Insulin Pumps Industry to 2028 - Featuring Tandem Diabetes Care, F. Hoffmann-La Roche, Ypsomed and Valeritas Among Others -

Nov 2, 2022

The report on the global insulin pumps market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global insulin pumps market to grow with a CAGR of 14% over the forecast period from 2022-2028. The study on insulin pumps market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028. The report on insulin pumps market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global insulin pumps market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings. Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global insulin pumps market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider. Report Findings What does this Report Deliver? 1. Comprehensive analysis of the global as well as regional markets of the insulin pumps market. 2. Complete coverage of all the segments in the insulin pumps market to analyze the trends, developments in the global market and forecast of market size up to 2028. 3. Comprehensive analysis of the companies operating in the global insulin pumps market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify. For more information about this report visit Contacts

Valeritas Frequently Asked Questions (FAQ)

  • When was Valeritas founded?

    Valeritas was founded in 2006.

  • Where is Valeritas's headquarters?

    Valeritas's headquarters is located at 750 Route 202 South, Bridgewater.

  • What is Valeritas's latest funding round?

    Valeritas's latest funding round is Acquired.

  • How much did Valeritas raise?

    Valeritas raised a total of $281.59M.

  • Who are the investors of Valeritas?

    Investors of Valeritas include Zealand Pharma, Valeritas, Welsh Carson Anderson & Stowe, ONSET Ventures, Pitango Venture Capital and 12 more.

  • Who are Valeritas's competitors?

    Competitors of Valeritas include PharmaJet, Hutchison MediPharma, Phreesia, Pantec Biosolutions, Replenish and 13 more.

Compare Valeritas to Competitors


BioValve offers drug delivery systems


UMD aims to develop drug delivery technologies and products, with a focus on women's health.

The Liposome Company

The Liposome Company is developing liposome-based drug delivery


Depotech is developing methods for drug delivery


Cytogel, Inc., is working on the development of promising drug candidates and drug delivery technologies


Replenish Inc is a Pasadena, Calif.-based developer of a drug delivery platform.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.